Literature DB >> 7679987

Impaired stimulus-evoked mucus secretion in cystic fibrosis bronchi.

D F Rogers1, E W Alton, A Dewar, M I Lethem, P J Barnes.   

Abstract

Baseline and agonist-stimulated secretion of fucose, hexose, and protein (markers of mucus secretion) was investigated in vitro in 45 bronchial segments from 14 patients with cystic fibrosis (CF) (three after heart-lung transplant, the remainder < 4.5 h after autopsy), in 51 segments from 26 patients with carcinoma (24 resection, 2 after autopsy), and in 4 segments from 3 patients with bronchiectasis (resection). Basal rates of secretion of each mucus marker by CF bronchi were not significantly different from those by carcinoma bronchi bronchiectatic bronchi. However, rates of secretion of each marker in response to the cholinomimetic methacholine (10 microM; n = 11-18, depending on marker) and the beta 2-adrenoceptor agonist terbutaline (10 microM; n = 9-11) were significantly (p < .05) increased in carcinoma bronchi (by 50-117% above basal), but not in CF airways (n = 11-14). The secretory response to the sensory neuropeptide substance P (1 nM to 10 microM; n = 5-7) was also reduced in CF compared with carcinoma bronchi. Physiological and morphological data indicated that the reduced response by CF tissue could not be accounted for by inclusion of autopsy tissue in the study. These data suggest a defect in autonomic control of bronchial secretion in CF, not in the basal rate of secretion, but in its response to receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679987     DOI: 10.3109/01902149309071079

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  4 in total

1.  Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process.

Authors:  Jae Young Choi; Monal Khansaheb; Nam Soo Joo; Mauri E Krouse; Robert C Robbins; David Weill; Jeffrey J Wine
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

Review 2.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

3.  Correlation of apical fluid-regulating channel proteins with lung function in human COPD lungs.

Authors:  Runzhen Zhao; Xinrong Liang; Meimi Zhao; Shan-Lu Liu; Yao Huang; Steven Idell; Xiumin Li; Hong-Long Ji
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

Review 4.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.